<DOC>
	<DOC>NCT01376089</DOC>
	<brief_summary>The purpose of this study is to evaluate and compare overall patient comfort profile between the Iso-osmolar contrast media (IOCM), iodixanol 320 mg I/mL, and a Low-osmolar contrast media (LOCM), iopamidol 370 mg I/mL in patients undergoing Contrast-Enhanced Computed Tomographic (CECT) imaging of the abdomen/pelvis.</brief_summary>
	<brief_title>Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis</brief_title>
	<detailed_description />
	<criteria>The subject is over 18 years old. Subjects are referred to undergo a CECT imaging of the abdomen/pelvis as part of their routine clinical care. The subject has known allergies to iodine or any prior history of adverse reaction to iodinated CM. The subject received another administration of CM within 24 hours prior to baseline or is scheduled to receive one within the 24 hour followup period. The subject is pregnant. The subject is taking metformin (e.g., GlucophageÂ®) but is not willing or unable to discontinue at the time of the study procedure. The subject manifests thyrotoxicosis or is on dialysis.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Safety</keyword>
</DOC>